SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001636050-19-000053
Filing Date
2019-06-11
Accepted
2019-06-11 17:24:07
Documents
83
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-K axovant3311910k.htm 10-K 1755072
2 EXHIBIT 10.20 axovantexhibit1020.htm EX-10.20 109063
3 EXHIBIT 10.21 axovantexhibit1021.htm EX-10.21 193715
4 EXHIBIT 10.22 axovantexhibit1022.htm EX-10.22 178189
5 EXHIBIT 21.1 axovantexhibit211.htm EX-21.1 8876
6 EXHIBIT 23.1 axovantexhibit231.htm EX-23.1 5277
7 EXHIBIT 31.1 axovantexhibit311.htm EX-31.1 10223
8 EXHIBIT 31.2 axovantexhibit312.htm EX-31.2 10366
9 EXHIBIT 32.1 axovantexhibit321.htm EX-32.1 6478
10 EXHIBIT 32.2 axovantexhibit322.htm EX-32.2 6634
  Complete submission text file 0001636050-19-000053.txt   7281805

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT axon-20190331.xml EX-101.INS 1059607
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axon-20190331.xsd EX-101.SCH 56684
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axon-20190331_cal.xml EX-101.CAL 81572
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axon-20190331_def.xml EX-101.DEF 262610
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axon-20190331_lab.xml EX-101.LAB 706529
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axon-20190331_pre.xml EX-101.PRE 441599
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FLOOR LONDON X0 SW1Y 4LB 44 203 318 9708
Axovant Gene Therapies Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37418 | Film No.: 19891827
SIC: 2834 Pharmaceutical Preparations